The estimated Net Worth of Donna Shiroma is at least $945 Тысяча dollars as of 21 August 2023. Ms Shiroma owns over 4,193 units of AVITA Medical Inc stock worth over $404,399 and over the last 4 years she sold RCEL stock worth over $66,417. In addition, she makes $473,706 as Gen. Counsel & Sec. at AVITA Medical Inc.
Ms has made over 1 trades of the AVITA Medical Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently she sold 4,193 units of RCEL stock worth $66,417 on 21 August 2023.
The largest trade she's ever made was selling 4,193 units of AVITA Medical Inc stock on 21 August 2023 worth over $66,417. On average, Ms trades about 599 units every 0 days since 2020. As of 21 August 2023 she still owns at least 42,257 units of AVITA Medical Inc stock.
You can see the complete history of Ms Shiroma stock trades at the bottom of the page.
Donna Shiroma is the Gen. Counsel & Sec. at AVITA Medical Inc.
As the Gen. Counsel & Sec. of AVITA Medical Inc, the total compensation of Ms Shiroma at AVITA Medical Inc is $473,706. There are 3 executives at AVITA Medical Inc getting paid more, with Dr. Michael S. Perry D.V.M., DVM, FACVPT, Ph.D. having the highest compensation of $1,058,847.
Ms Shiroma is 59, she's been the Gen. Counsel & Sec. of AVITA Medical Inc since . There are 1 older and 4 younger executives at AVITA Medical Inc. The oldest executive at AVITA Medical Inc is Dr. Michael S. Perry D.V.M., DVM, FACVPT, Ph.D., 62, who is the CEO, Pres & Exec. Director.
Donna's mailing address filed with the SEC is 28159 AVENUE STANFORD, SUITE 220 - AVITA MEDICAL, VALENCIA, CA, 91355.
Over the last 5 years, insiders at AVITA Medical Inc have traded over $2,850,472 worth of AVITA Medical Inc stock and bought 19,459 units worth $293,310 . The most active insiders traders include Michael S Perry, James Corbett и David D O'toole. On average, AVITA Medical Inc executives and independent directors trade stock every 82 days with the average trade being worth of $135,636. The most recent stock trade was executed by David D O'toole on 30 May 2024, trading 1,000 units of RCEL stock currently worth $8,900.
avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company’s lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.
AVITA Medical Inc executives and other stock owners filed with the SEC include: